Published in Medical Letter on the CDC and FDA, September 1st, 2002
The FDA document said that alternatives to DEHP-containing PVC medical devices should be used when possible for certain medical procedures. However, the FDA failed to require labeling of DEHP-containing medical devices, leaving healthcare providers with no way of knowing which products are leaching potentially unsafe doses of DEHP.
"FDA's Public Health Notification falls far short of what...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.